(CRBG) Corebridge Financial - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US21871X1090

Annuities, Life Insurance, Retirement Plans, Institutional Products

Stock: Diversified Financial Services
Age 3.4y

MCap 14,839m
Avg Vol 3.91M (119M USD)

Beta 1.388
Volatility 30.28%

EPS (Earnings per Share)

EPS CAGR: -35.29%
EPS Trend: -52.5%

Last SUE: -1.30
Qual. Beats: 0

Revenue

Rev. CAGR: -45.28%
Rev. Trend: -21.9%

Last SUE: -0.68
Qual. Beats: 0

Dividends

Dividend Yield	3.04%
Yield on Cost 5y	5.85%
Yield CAGR 5y	27.79%
Payout Consistency	76.8%
Payout Ratio	65.8%

Risk via 5d forecast
Volatility	30.3%
Value at Risk 5%th	49.2%
Relative Tail Risk	-1.17%

Reward TTM
Sharpe Ratio	-0.09
Alpha	-26.62
CAGR/Max DD	0.61

Character TTM
Hurst Exponent	0.420
Beta	1.388
Beta Downside	1.749

Drawdowns 3y
Max DD	32.88%
Mean DD	8.92%
Median DD	7.65%

Description: CRBG Corebridge Financial December 19, 2025

Corebridge Financial, Inc. (NYSE: CRBG) delivers retirement and insurance solutions across four business lines: Individual Retirement (fixed, indexed, and variable annuities), Group Retirement (in-plan recordkeeping, flexible annuities, and advisory services), Life Insurance (term, whole, index universal, and guaranteed universal life), and Institutional Markets (stable-value wraps, pension-risk-transfer annuities, private-placement life and annuity products, and guaranteed investment contracts). The firm, originally SAFG Retirement Services, was founded in 1998 and is headquartered in Houston, Texas.

Key recent metrics: Q3 2024 reported a 7% YoY increase in annuity premium volume, driven by rising interest-rate spreads that make fixed-index products more attractive; the Life Insurance segment posted a combined ratio of 92.3%, indicating underwriting profitability despite a competitive market. Macro-level drivers include the aging U.S. population-projected to push the 65-plus cohort to 22% of the population by 2030-and the Fed’s policy cycle, which influences the pricing of fixed-income-linked annuities and stable-value wraps.

For a deeper dive into CRBG’s valuation nuances, consider exploring ValueRay’s analytical tools.

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income: 991.0m TTM > 0 and > 6% of Revenue
FCF/TA: 0.00 > 0.02 and ΔFCF/TA -0.16 > 1.0
NWC/Revenue: 1939 % < 20% (prev 2579 %; Δ -640.7% < -1%)
CFO/TA 0.00 > 3% & CFO 1.62b > Net Income 991.0m
Net Debt (10.70b) to EBITDA (2.42b): 4.42 < 3
Current Ratio: 6.96 > 1.5 & < 3
Outstanding Shares: last quarter (540.6m) vs 12m ago -7.92% < -2%
Gross Margin: 80.35% > 18% (prev 0.79%; Δ 7956 % > 0.5%)
Asset Turnover: 0.71% > 50% (prev 0.64%; Δ 0.06% > 0%)
Interest Coverage Ratio: 3.50 > 6 (EBITDA TTM 2.42b / Interest Expense TTM 565.0m)

Altman Z'' 1.08

A: 0.14 (Total Current Assets 65.09b - Total Current Liabilities 9.36b) / Total Assets 411.29b
B: 0.04 (Retained Earnings 17.68b / Total Assets 411.29b)
C: 0.00 (EBIT TTM 1.98b / Avg Total Assets 405.36b)
D: 0.02 (Book Value of Equity 8.66b / Total Liabilities 396.97b)
Altman-Z'' Score: 1.08 = BB

Beneish M

DSRI: 0.81 (Receivables 621.0m/690.0m, Revenue 2.88b/2.58b)
GMI: 0.98 (GM 80.35% / 78.73%)
AQI: none (AQ_t none / AQ_t-1 none)
SGI: 1.12 (Revenue 2.88b / 2.58b)
TATA: -0.00 (NI 991.0m - CFO 1.62b) / TA 411.29b)
Beneish M-Score: cannot calculate (missing components)

ValueRay F-Score (Strict, 0-100) 49.63

1. Piotroski: 3.50pt
2. FCF Yield: -4.19%
3. FCF Margin: 56.31%
4. Debt/Equity: 0.81
5. Debt/Ebitda: 4.42
6. ROIC - WACC: -0.29%
7. RoE: 8.04%
8. Revenue Trend: -21.89%
9. EPS Trend: -52.50%

What is the price of CRBG shares?

As of January 28, 2026, the stock is trading at USD 30.22 with a total of 3,067,048 shares traded.
Over the past week, the price has changed by +2.72%, over one month by -0.72%, over three months by -5.26% and over the past year by -5.32%.

Is CRBG a buy, sell or hold?

Corebridge Financial has received a consensus analysts rating of 4.07. Therefore, it is recommended to buy CRBG.

Strong Buy: 6
Buy: 5
Hold: 2
Sell: 0
Strong Sell: 1

What are the forecasts/targets for the CRBG price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	37.7	24.7%
Analysts Target Price	37.7	24.7%
ValueRay Target Price	34.3	13.5%

CRBG Fundamental Data Overview January 22, 2026

P/E Trailing = 20.0136
P/E Forward = 5.8309
P/S = 0.8093
P/B = 1.1356
Revenue TTM = 2.88b USD
EBIT TTM = 1.98b USD
EBITDA TTM = 2.42b USD
Long Term Debt = 11.02b USD (from longTermDebt, last quarter)
Short Term Debt = 9.36b USD (from shortTermDebt, last quarter)
Debt = 11.02b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.70b USD (from netDebt column, last quarter)
Enterprise Value = -38.62b USD (14.84b + Debt 11.02b - CCE 64.47b)
Interest Coverage Ratio = 3.50 (Ebit TTM 1.98b / Interest Expense TTM 565.0m)
EV/FCF = -23.85x (Enterprise Value -38.62b / FCF TTM 1.62b)
FCF Yield = -4.19% (FCF TTM 1.62b / Enterprise Value -38.62b)
FCF Margin = 56.31% (FCF TTM 1.62b / Revenue TTM 2.88b)
Net Margin = 34.47% (Net Income TTM 991.0m / Revenue TTM 2.88b)
Gross Margin = 80.35% ((Revenue TTM 2.88b - Cost of Revenue TTM 565.0m) / Revenue TTM)
Gross Margin QoQ = 81.35% (prev 81.41%)
Tobins Q-Ratio = -0.09 (set to none) (Enterprise Value -38.62b / Total Assets 411.29b)
Interest Expense / Debt = 1.23% (Interest Expense 135.0m / Debt 11.02b)
Taxrate = 21.41% (600.0m / 2.80b)
NOPAT = 1.55b (EBIT 1.98b * (1 - 21.41%))
Current Ratio = 6.96 (Total Current Assets 65.09b / Total Current Liabilities 9.36b)
Debt / Equity = 0.81 (Debt 11.02b / totalStockholderEquity, last quarter 13.54b)
Debt / EBITDA = 4.42 (Net Debt 10.70b / EBITDA 2.42b)
Debt / FCF = 6.61 (Net Debt 10.70b / FCF TTM 1.62b)
Total Stockholder Equity = 12.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.24% (Net Income 991.0m / Total Assets 411.29b)
RoE = 8.04% (Net Income TTM 991.0m / Total Stockholder Equity 12.32b)
RoCE = 8.48% (EBIT 1.98b / Capital Employed (Equity 12.32b + L.T.Debt 11.02b))
RoIC = 6.45% (NOPAT 1.55b / Invested Capital 24.09b)
WACC = 6.74% (E(14.84b)/V(25.85b) * Re(11.03%) + D(11.02b)/V(25.85b) * Rd(1.23%) * (1-Tc(0.21)))
Discount Rate = 11.03% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -7.59%
[DCF Debug] Terminal Value 83.89% ; FCFF base≈1.85b ; Y1≈2.02b ; Y5≈2.53b
Fair Price DCF = 94.34 (EV 58.29b - Net Debt 10.70b = Equity 47.59b / Shares 504.4m; r=6.74% [WACC]; 5y FCF grow 10.00% → 2.90% )
EPS Correlation: -52.50 | EPS CAGR: -35.29% | SUE: -1.30 | # QB: 0
Revenue Correlation: -21.89 | Revenue CAGR: -45.28% | SUE: -0.68 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.20 | Chg30d=-0.019 | Revisions Net=-6 | Analysts=12
EPS next Year (2026-12-31): EPS=5.23 | Chg30d=-0.140 | Revisions Net=-9 | Growth EPS=+19.6% | Growth Revenue=+7.7%

Additional Sources for CRBG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle